Awards & Grants,
Molecular Targets and Therapeutics,
MCD,
Marcus Conrad Receives German Cancer Award 2026
Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death at Helmholtz Munich was awarded the German Cancer Award 2026 in the category “Experimental Research”, together with Prof. José Pedro Friedmann Angeli of the University of…
Rethinking Early Detection: Type 1 Diabetes in Young Adults
A population-based cohort study provides new data on the prevalence of early-stage type 1 diabetes in young adults, addressing a gap in epidemiological research. Using samples from the LISA and GINIplus cohorts and methodologies established in the…
Lipid Identification: Chemical Fingerprint Instead of Dye
A team at Helmholtz Munich and the Technical University of Munich (TUM) has developed a new microscopy technique that can distinguish lipid species in living cells – in particular cholesterol and sphingomyelin – and map them without the need for…
Events,
Diabetes,
IDR,
Computational Health,
Health AI,
Helmholtz Munich Expert Hour: Bringing Research Effectively into Healthcare
How can scientific breakthroughs reach the people more quickly? This question was the focus of the Helmholtz Munich Expert Hour on March 25 in the German Bundestag. Under the title “From Research to Patients – Translation and AI in Medicine”,…
